Vertex Pharmaceuticals Incorporated (VRTX)

BiotechnologyHealthcare

229.06-4.85(-2.07%)

26/01/2020 19:13:54


52 Week L/H
164.61
235.83

VRTX Stock Price Chart


Fundamental ratios

Price-to-Earnings Ratio (TTM)
26.5
Price-to-Earnings Ratio (5 year avg)
23.5
Enterprise-value-to-EBITDA ratio
8.31
Price-to-book ratio
10.72
Price/Earnings-to-Growth Ratio
0.12
EV/Invested Capital
52,919 Million

Profitability ratios

Return on Invested Capital
47.0
Return on Invested Capital average (5y)
8.18
Return on Equity
1.76
Return on Equity average (5y)
4.42
Return on Assets
0.4
Return on Assets average (5y)
4.1

Growth rates

Revenue growth
Revenue growth 5y CAGR
NA
EBITDA growth
NA
EBITDA 5y CAGR
NA
Net Income growth
NA
Net Income 5y CAGR

Stock Margins

Gross Margin
86.6
Gross Margin Average (5y)
NA
EBITDA Margin
24.2
EBITDA Margin Average (5y)
NA
Net Margin
259.1
Net Margin average (5y)
-22.1

Risk and leverage

Max. Drawdown 5yNA
Return over Max Drawdown (5y)1.74%
Max. Drawdown since GR-54.15%
Return over Max D. Since GR
Debt to Equity
0.12
Interest Coverage Ratio
31.5

Dividends and its sustainability

Dividend Yield
NA
Dividend per share
NA
DPS 5y CAGR
NA
Dividend payout ratio
0.0
Dividend to FCF
NA
Payout Ratio
0.0

Basic Information

Earnings per Share (EPS)
8.39
EPS Estimate Currrent Qtr
0.95
Book Value Per Share
20.43
Market Cap
56,311 Million
PE Ratio
26.5
Enterprise Value
52,919 Million
Invested Capital
19,482 Million

Stock Yield

Stock Return 7 Days -2.11%
Stock Return 15 Days1.13%
Stock Return 30 Days3.66%
Stock Return 3 Months18.06%
Stock Return One Year21.78%
Stock Return 3 Years168.44%

Note: Calculations based on previous day's adjusted closing prices

Stock Technical Analysis

Relative Strengh Index (14)
54.96
Momentum (14)
-11.08
Simple Moving Average (14)
230.82
Exponential Moving Average (14)
230.32
Average True Range
4.46

Note: Calculations based on previous day's adjusted closing prices